top of page

Reglagene was awarded 2nd out of 34 entrants from across the nation in the Innovators Pitch Challenge at the #RESI conference! We are proud to be recognized among the top innovators in our field and grateful for the opportunity to showcase our cutting-edge solution for brain cancer.

This achievement is a testament to the hard work and dedication of our team and the innovative spirit that drives our company forward. We are excited to continue pushing the boundaries of what's possible and continue development on a new therapy for patients afflicted with brain cancer.

Thank you to the RESI contest organizers for hosting such a fantastic event and to the pharmaceutical industry representatives and venture capitalists who served as judges. We look forward to continued collaboration and growth in the coming years.


Thank you to Life Science Nation for selecting Reglagene to participate in the Innovator Pitch Challenge Oncology Therapeutics Vertical. Thank you to the judges from Bayer, Boehringer Ingelheim, Bernina Bioinvest, Norwest Venture Partners, and Analytics Ventures for the great questions! Congratulations to GV20 Therapeutics, f5 Therapeutics Incorporated, and TATUM bioscience for the exciting presentations.

Reglagene has been selected as one of 16 companies for the AZ Inno Madness Competition! Please help us become the 2023 Inno Madness Champion by clicking the link on this post and voting for Reglagene. The first round of voting ends March 13th, so please vote soon! #Biotech#Arizona#CureCancer

bottom of page